Literature DB >> 25592446

Which is the best advanced MR imaging protocol for predicting recurrent metastatic brain tumor following gamma-knife radiosurgery: focused on perfusion method.

Myeong Ju Koh1, Ho Sung Kim, Choong Gon Choi, Sang Joon Kim.   

Abstract

INTRODUCTION: High spatial resolution of dynamic contrast-enhanced (DCE) MR imaging allows characterization of heterogenous tumor microenvironment. Our purpose was to determine which is the best advanced MR imaging protocol, focused on additional MR perfusion method, for predicting recurrent metastatic brain tumor following gamma-knife radiosurgery (GKRS).
METHODS: Seventy-two consecutive patients with post-GKRS metastatic brain tumor were enrolled. Two readers independently calculated the percentile histogram cutoffs for normalized cerebral blood volume (nCBV) from dynamic susceptibility contrast (DSC) imaging and initial area under the time signal-intensity curve (IAUC) from DCE imaging, respectively. Area under the receiver operating characteristic curve (AUC) and interreader agreement were assessed.
RESULTS: For differentiating tumor recurrence from therapy effect, adding DCE imaging to diffusion-weighted imaging (DWI) significantly improved AUC from 0.79 to 0.95 for reader 1 and from 0.80 to 0.96 for reader 2, respectively. There was no significant difference of AUC between the combination of DWI with DSC imaging and the combination of DWI with DCE imaging for both readers. With the combination of DWI and DCE imaging, the sensitivity and specificity were 86.7 and 88.1% for reader 1 and 90.0 and 85.7% for reader 2, respectively. The intraclass correlation coefficient (ICC) between readers was highest for calculation of the 90th percentile histogram cutoffs for IAUC (ICC, 0.87).
CONCLUSION: Adding perfusion MR imaging to DWI significantly improves the prediction of recurrent metastatic tumor; however, the diagnostic performance is not affected by selection of either DSC or DCE MR perfusion method.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592446     DOI: 10.1007/s00234-015-1485-9

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  24 in total

1.  Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies.

Authors:  Caleb Roberts; Basma Issa; Andrew Stone; Alan Jackson; John C Waterton; Geoffrey J M Parker
Journal:  J Magn Reson Imaging       Date:  2006-04       Impact factor: 4.813

2.  Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.

Authors:  Jiayi Huang; Ay-Ming Wang; Anil Shetty; Ann H Maitz; Di Yan; Danielle Doyle; Kenneth Richey; Sean Park; Daniel R Pieper; Peter Y Chen; Inga Siiner Grills
Journal:  Magn Reson Imaging       Date:  2011-05-14       Impact factor: 2.546

3.  Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters.

Authors:  C Chad Quarles; John C Gore; Lei Xu; Thomas E Yankeelov
Journal:  Magn Reson Imaging       Date:  2012-05-21       Impact factor: 2.546

4.  Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging.

Authors:  Sotirios Bisdas; Thomas Naegele; Rainer Ritz; Artemisia Dimostheni; Christina Pfannenberg; Matthias Reimold; Tong San Koh; Ulrike Ernemann
Journal:  Acad Radiol       Date:  2011-03-21       Impact factor: 3.173

5.  Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients.

Authors:  K M Donahue; H G Krouwer; S D Rand; A P Pathak; C S Marszalkowski; S C Censky; R W Prost
Journal:  Magn Reson Med       Date:  2000-06       Impact factor: 4.668

6.  Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.

Authors:  N A Mayr; W T Yuh; J Zheng; J C Ehrhardt; V A Magnotta; J I Sorosky; R E Pelsang; L W Oberley; D H Hussey
Journal:  AJR Am J Roentgenol       Date:  1998-01       Impact factor: 3.959

7.  Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme.

Authors:  Axel Gossmann; Thomas H Helbich; Nagato Kuriyama; S Ostrowitzki; Timothy P L Roberts; David M Shames; N van Bruggen; Michael F Wendland; Mark A Israel; Robert C Brasch
Journal:  J Magn Reson Imaging       Date:  2002-03       Impact factor: 4.813

8.  Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.

Authors:  Emerson L Gasparetto; Mikolaj A Pawlak; Sohil H Patel; Jason Huse; John H Woo; Jaroslaw Krejza; Myrna R Rosenfeld; Donald M O'Rourke; Robert Lustig; Elias R Melhem; Ronald L Wolf
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

9.  Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  R F Barajas; J S Chang; P K Sneed; M R Segal; M W McDermott; S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2008-11-20       Impact factor: 3.825

10.  Management of single brain metastasis: a practice guideline.

Authors:  A Mintz; J Perry; K Spithoff; A Chambers; N Laperriere
Journal:  Curr Oncol       Date:  2007-08       Impact factor: 3.677

View more
  4 in total

1.  Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.

Authors:  Timothy J Kaufmann; Marion Smits; Jerrold Boxerman; Raymond Huang; Daniel P Barboriak; Michael Weller; Caroline Chung; Christina Tsien; Paul D Brown; Lalitha Shankar; Evanthia Galanis; Elizabeth Gerstner; Martin J van den Bent; Terry C Burns; Ian F Parney; Gavin Dunn; Priscilla K Brastianos; Nancy U Lin; Patrick Y Wen; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

Review 2.  Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.

Authors:  Chong Hyun Suh; Ho Sung Kim; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim
Journal:  Eur Radiol       Date:  2018-04-04       Impact factor: 5.315

3.  Dynamic susceptibility MR perfusion in diagnosing recurrent brain metastases after radiotherapy: A systematic review and meta-analysis.

Authors:  Robert M Kwee; Thomas C Kwee
Journal:  J Magn Reson Imaging       Date:  2019-05-31       Impact factor: 4.813

4.  Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial.

Authors:  Paul Lesueur; William Kao; Alexandra Leconte; Julien Geffrelot; Justine Lequesne; Joëlle Lacroix; Pierre-Emmanuel Brachet; Ioana Hrab; Philippe Royer; Bénédicte Clarisse; Dinu Stefan
Journal:  BMC Cancer       Date:  2020-02-22       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.